Consensus cbdMD, Inc.

Stocks

YCBD

US12482W4087

Pharmaceuticals

Real-time Estimate Cboe BZX 23:52:19 01/10/2026 +04			5-day change	1st Jan Change
0.4530 ^USD	0.00%		-1.87%	-66.64%

09-02	CbdMD, Inc. entered into a definitive asset purchase agreement to acquire Operating assets and brands of Twinlab Consolidation Corporation for $2.9 million.	CI
08-17	Maxim Group Downgrades cbdMD to Hold From Buy	MT

Evolution of the Average Target: cbdMD, Inc.

Evolution of the Target Price: cbdMD, Inc.

Changes in Analyst Recommendations: cbdMD, Inc.

09a0a695da.KX3-lnLCqTP7RrmjcAVH7XMWB2XQAi3SmY8FCUiRybU.exC34giLw3uhPtHLGXcltAp5ND20MWPgz8dUZwGnguZNE42kHvP5Z78_zg~8ced607cd7cc07a131df5aa35e05e5d7

Analysts' recommendations: cbdMD, Inc.

08-17	Maxim Group Downgrades cbdMD to Hold From Buy	MT
05/10/23	Maxim Starts Coverage on cbdMD with Buy Rating, $3 Price Target	MT
18/06/21	CbdMD : Cantor Fitzgerald Adjusts Price Target for cbdMD to $3.25 from $4.10, Maintains Neutral Rating	MT

More recommendations

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CBDMD, INC.			-	-	-
	ELI LILLY AND COMPANY					+14.84%
	JOHNSON & JOHNSON					+5.49%
	ABBVIE INC.					+6.6%
	MERCK & CO., INC.					+7.19%
	ROCHE HOLDING AG					+7.52%
	NOVARTIS AG					+5.92%
	ASTRAZENECA PLC					+29.21%
	AMGEN INC.					-7.25%
	GILEAD SCIENCES, INC.					+6.44%
	Average					+8.44%
	Weighted average by Cap.					+9.43%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

HOLD

Number of Analysts

1

Last Close Price

0.4530

Average target price

-

Analyst Consensus Detail

Consensus revision (last 18 months)

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
YCBD Stock
Consensus cbdMD, Inc.

As early as today, start finding the best investment opportunities!